Literature DB >> 11711049

Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed.

B J De Witt1, J R Marrone, A D Kaye, L K Keefer, P J Kadowitz.   

Abstract

Pulmonary vascular responses to the novel diazeniumdiolate nitric oxide (NO) donors diethylamine/NO, diethylenetriamine/NO, spermine/NO, sulfite/NO, and angeli's salt, were investigated and compared in the intact-chest cat. Under conditions of controlled blood flow, when tone in the pulmonary vascular bed had been raised to a high steady level, intralobar injections of diethylamine/NO (0.3-10 microg), diethylenetriamine/NO (10-30 microg), spermine/NO (10-30 microg), sulfite/NO (10-30 microg), and angeli's salt (10-30 microg) caused dose-related decreases in lobar arterial pressure without changing left atrial pressure. In terms of relative vasodilator activity in the pulmonary vascular bed, the dose of the compounds that decreased lobar arterial pressure 4 mm Hg (ED(4) mm Hg) was significantly lower for diethylamine/NO compared to S-nitroso-N-acetylpenicillamine which was significantly less than diethylenetriamine/NO, spermine/NO, sulfite/NO, and angeli's salt. The half-life of the vasodilator responses, as measured by 50% response recovery time, to diethylamine/NO, diethylenetriamine/NO, spermine/NO, sulfite/NO, and angeli's salt was similar for doses with similar magnitudes of vasodilation, while the half-life to S-nitroso-N-acetylpenicillamine was significantly less than the diazeniumdiolate NO donors. The present data demonstrate that the diazeniumdiolate NO donors diethylamine/NO, diethylenetriamine/NO, spermine/NO, sulfite/NO, and angeli's salt have potent but relatively short-lasting vasodilator activity in the pulmonary vascular bed of the cat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711049     DOI: 10.1016/s0014-2999(01)01289-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

Review 1.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

2.  Nitroxyl donors retain their depressor effects in hypertension.

Authors:  Jennifer C Irvine; Ravina M Ravi; Barbara K Kemp-Harper; Robert E Widdop
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-12       Impact factor: 4.733

3.  Rapid and selective nitroxyl (HNO) trapping by phosphines: kinetics and new aqueous ligations for HNO detection and quantitation.

Authors:  Julie A Reisz; Charles N Zink; S Bruce King
Journal:  J Am Chem Soc       Date:  2011-07-11       Impact factor: 15.419

4.  A selective phosphine-based fluorescent probe for nitroxyl in living cells.

Authors:  Zhengrui Miao; Julie A Reisz; Susan M Mitroka; Jia Pan; Ming Xian; S Bruce King
Journal:  Bioorg Med Chem Lett       Date:  2014-11-21       Impact factor: 2.823

5.  Kinetic feasibility of nitroxyl reduction by physiological reductants and biological implications.

Authors:  Matthew I Jackson; Tae H Han; Laura Serbulea; Andrew Dutton; Eleonora Ford; Katrina M Miranda; K N Houk; David A Wink; Jon M Fukuto
Journal:  Free Radic Biol Med       Date:  2009-07-02       Impact factor: 7.376

6.  Pharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.

Authors:  Sonia Donzelli; Gerry Fischer; Bruce S King; Christin Niemann; Jenna F DuMond; Jörg Heeren; Hartwig Wieboldt; Stephan Baldus; Christian Gerloff; Thomas Eschenhagen; Lucie Carrier; Rainer H Böger; Michael Graham Espey
Journal:  J Pharmacol Exp Ther       Date:  2012-12-04       Impact factor: 4.030

7.  Key bioactive reaction products of the NO/H2S interaction are S/N-hybrid species, polysulfides, and nitroxyl.

Authors:  Miriam M Cortese-Krott; Gunter G C Kuhnle; Alex Dyson; Bernadette O Fernandez; Marian Grman; Jenna F DuMond; Mark P Barrow; George McLeod; Hidehiko Nakagawa; Karol Ondrias; Péter Nagy; S Bruce King; Joseph E Saavedra; Larry K Keefer; Mervyn Singer; Malte Kelm; Anthony R Butler; Martin Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-29       Impact factor: 11.205

8.  Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine.

Authors:  Sonia Donzelli; Michael Graham Espey; Wilmarie Flores-Santana; Christopher H Switzer; Grace C Yeh; Jinming Huang; Dennis J Stuehr; S Bruce King; Katrina M Miranda; David A Wink
Journal:  Free Radic Biol Med       Date:  2008-05-03       Impact factor: 7.376

9.  Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

Authors:  Barbara K Kemp-Harper; Anida Velagic; Nazareno Paolocci; John D Horowitz; Rebecca H Ritchie
Journal:  Handb Exp Pharmacol       Date:  2021

10.  The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.

Authors:  Thomas W Miller; Melisa M Cherney; Andrea J Lee; Nestor E Francoleon; Patrick J Farmer; S Bruce King; Adrian J Hobbs; Katrina M Miranda; Judith N Burstyn; Jon M Fukuto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.